Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Application of Photodynamic Therapy in Dermatology"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2711
Special Issue Editors
2. Department of Cosmetology and Aesthetic Dermatology, Medical University of Lublin, 20-081 Lublin, Poland
Interests: psoriasis; chronic urticaria; photodynamic therapy; actinic keratosis; skin cancers; cosmetics
Special Issues, Collections and Topics in MDPI journals
Interests: photodynamic therapy; photosensitizers; combination therapies; drug delivery systems; photodiagnosis; immunomodulation; dosimetry; fluorescence; skin diseases; malignancy
Special Issue Information
Owing to its relatively non-invasive nature, good tolerability, low systemic toxicity, and ability to produce a desirable cosmetic outcome, photodynamic therapy (PDT) has been employed in many medical applications. It has been proven to be an effective therapeutic tool in the treatment of various skin conditions, such as actinic keratosis/cheilitis, NMSC, photoaging, acne, rosacea, sebaceous hyperplasia, and verrucae, to name just a few. PDT is also used in the diagnosis of various types of cancer, as well as in the treatment of some infectious and autoimmune diseases.
In PDT, in order to induce photochemical and photobiological reactions that are destined to destroy the targeted, pathologically changed cells, a combination of three elements, i.e., a photosensitizer, oxygen, and light, is required. The most popular types of topical photosensitizer prodrugs used in PDT are 5-aminolevulinic acid (5-ALA) and its derivatives.
Although the PDT method is being continuously improved, it still has limitations and awaits perfecting. Thus, in order to devise new ways to enhance its efficacy, produce more efficient photosensitizers and new light sources, further scientific studies are necessary.
Therefore, we would be delighted to receive research articles, reviews, communications and case studies that shed more light onto any new approaches to improve the efficacy of PDT, as well as papers pertaining to PDT-associated immunotherapy, new radiation systems and new light-delivering devices.
Prof. Dr. Joanna Bartosińska
Dr. Dorota Kowalczuk
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- photodynamic therapy
- combination therapies
- drug delivery systems
- skin diseases